Phase I Trial of TAS-102 and Concurrent Radiation Therapy for Patients With Locally Recurrent, Unresectable or Metastatic, Rectal Cancer
Phase of Trial: Phase I
Latest Information Update: 11 Jul 2018
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Adenocarcinoma; Rectal cancer
- Focus Adverse reactions
- 29 Jun 2018 Status changed from suspended to recruiting.
- 05 Jun 2018 Study design presented at the 54th Annual Meeting of the American Society of Clinical Oncology. This trial is currently accruing patients to the first cohort.
- 08 May 2018 Status changed from recruiting to suspended.